Dublin, April 03, 2019 (GLOBE NEWSWIRE) -- The "Global In Vitro Diagnostics (IVD) Market Analysis & Trends - Industry Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The Global In Vitro Diagnostics (IVD) Market is poised to grow strong during the forecast period 2017 to 2027 Some of the prominent trends that the market is witnessing include increasing demand for personalized medicine, potential opportunities for Physician Office Laboratories (POL) and rising occurrence of the chronic and infectious disorder. This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants, and the future investors. Report Highlights:

  • The report provides a detailed analysis of current and future market trends to identify the investment opportunities
  • Market forecasts till 2027, using estimated market values as the base numbers
  • Key market trends across the business segments, Regions and Countries
  • Key developments and strategies observed in the market
  • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
  • In-depth company profiles of key players and upcoming prominent players
  • Growth prospects among the emerging nations through 2027
  • Market opportunities and recommendations for new investments

Key Topics Covered: 1 Market Outline 1.1 Research Methodology 1.2 Market Trends 1.3 Regulatory Factors 1.4 Technology Analysis 1.5 Product Analysis 1.6 End User Analysis 1.7 Application Analysis 1.8 Strategic Benchmarking 1.9 Opportunity Analysis 2 Executive Summary 3 Market Overview 3.1 Current Trends 3.1.1 Increasing Demand for Personalized Medicine 3.1.2 Potential Opportunities for Physician Office Laboratories (POL) 3.1.3 Rising Occurrence of the Chronic and Infectious Disorder 3.1.4 Growth Opportunities/Investment Opportunities 3.2 Drivers 3.3 Constraints 3.4 Industry Attractiveness 4 In Vitro Diagnostics (IVD) Market, By Technology 4.1 Clinical Chemistry 4.1.1 Liver Panel 4.1.2 Renal Profile 4.1.3 Basic Metabolic Panel 4.1.4 Thyroid Function Panel 4.1.5 Specialty Chemical Tests 4.1.6 Electrolyte Panel 4.1.7 Lipid Profile 4.1.8 Blood Gas Electrolyte Analyzers 4.2 Urinalysis 4.3 Microbiology 4.3.1 Pathological Culture 4.3.2 Identification & Antibiotic Susceptibility Testing 4.3.3 Blood Culture 4.3.4 Others 4.4 Hematology 4.4.1 Low Throughput Analyzer 4.4.2 Medium Throughput Analyzer 4.4.3 High Throughput Analyzer 4.5 Molecular Diagnostics 4.5.1 Microarray 4.5.2 Polymerase Chain Reaction 4.5.3 Hybridization 4.5.4 Deoxyribonucleic Acid (DNA) Sequencing & Next-Generation Sequencing 4.5.5 Isothermal Nucleic Acid Amplification Technology 4.5.6 Blood Screening 4.5.7 Genetic Diseases 4.5.8 Other Molecular Diagnostics Technologies 4.6 Immunoassay/Immunochemistry 4.6.1 Radioimmunoassay 4.6.2 Western Blotting 4.6.3 Enzyme-Linked Immunospot Assays 4.6.4 Rapid Test 4.6.5 Enzyme-Linked Immunosorbent Assay 4.6.5.1 Fluorescence Immunoassays 4.6.5.2 Colorimetric Immunoassays 4.6.5.3 Chemiluminescence Immunoassays 4.7 Coagulation and Hemostasis 4.8 Tissue Diagnostics 4.9 Other In Vitro Diagnostics (IVD) Technologies 4.9.1 Flow Cytometry 4.9.2 Clinical Centrifuges 4.9.3 Cytology 5 In Vitro Diagnostics (IVD) Market, By Product & Service 5.1 Services 5.2 Reagents & Kits 5.2.1 Genetic Testing 5.2.2 Other Reagents & Kits 5.3 Software 5.3.1 Data Management Software 5.3.2 Support Software 5.3.3 Middleware 5.3.4 Laboratory Information System (LIS) 5.3.5 Other Softwares 5.4 Instruments 5.4.1 Semi-Automated Instruments 5.4.2 Fully Automated Instruments 5.4.3 Cell Counting 5.4.4 Blood Grouping 5.4.5 Sample Processing 5.4.6 Other Instruments 6 In Vitro Diagnostics (IVD) Market, By Usability 6.1 Reusable 6.2 Disposable 7 In Vitro Diagnostics (IVD) Market, By End User 7.1 Point-Of-Care Testing 7.2 Hospitals 7.3 Academic & Medical Schools 7.4 Patient Self-Testing 7.5 Laboratories 7.5.1 Small & Medium-sized Laboratories 7.5.2 Large/Reference Laboratories 7.6 Home Care 7.7 Acute Wound 7.8 Other End Users 8 In Vitro Diagnostics (IVD) Market, By Application 8.1 Cardiology 8.2 Drug Testing/Pharmacogenomics 8.3 Oncology 8.4 Infectious Diseases 8.5 Diabetes 8.6 Autoimmune Diseases 8.7 Human Immunodeficiency Virus (HIV)/Aids 8.9 Nephrology 8.10 Gastrointestinal Diseases 8.11 Endocrinology 8.12 Other Applications 9 In Vitro Diagnostics (IVD) Market, By Geography 9.1 North America 9.1.1 US 9.1.2 Canada 9.1.3 Mexico 9.2 Europe 9.2.1 Germany 9.2.2 U.K 9.2.3 Italy 9.2.4 France 9.2.5 Spain 9.2.6 Rest of Europe 9.3 Asia Pacific 9.3.1 China 9.3.2 Japan 9.3.3 India 9.3.4 Australia 9.3.5 New Zealand 9.3.6 Rest of Asia Pacific 9.4 Middle East 9.4.1 Saudi Arabia 9.4.2 UAE 9.4.3 Rest of Middle East 9.5 Latin America 9.5.1 Argentina 9.5.2 Brazil 9.5.3 Rest of Latin America 9.6 Rest of the World (RoW) 9.6.1 South Africa 9.6.2 Others 10 Key Player Activities 10.1 Acquisitions & Mergers 10.2 Agreements, Partnerships, Collaborations and Joint Ventures 10.3 Product Launch & Expansions 10.4 Other Activities 11 Leading Companies 11.1 Siemens Healthcare 11.2 Roche Diagnostics 11.3 Thermo Fisher Scientific 11.4 Abbott Laboratories 11.5 Johnson and Johnson 11.6 Danaher Corporation 11.7 Agilent Technologies 11.8 Becton, Dickinson and Company 11.9 Sysmex Corporation 11.10 Bio-Rad Laboratories 11.11 Qiagen 11.12 Diasorin S.P.A. For more information about this report visit https://www.researchandmarkets.com/research/q...vitro?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: In Vitro Diagnostics